Bioelectronic Technology for Nutritional Research—a Novel In Vitro Platform for a Better Understanding of Human Gut Barrier Absorption
The epithelial gut barrier and gut microbiota significantly contribute to human health by controlling molecule absorption, a regulated transport that dictates bioavailability. Effective public health strategies, like dietary reference values, require a complete understanding of nutrient absorption. However, the lack of internationally harmonized nutritional recommendations indicates that gut barrier mechanisms are not fully unraveled. The conventional in vitro model Caco-2/HT29-MTX cultured on cell culture inserts, established for drug development, is limited in representing complex human gut physiology. The new bioelectronic e-transmembrane platform leverages technological and biological advances to generate more meaningful in vitro predictions. The soft electroactive Poly (3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) scaffold enables direct cell-electrode coupling for more sensitive barrier impedance measurements, especially required for testing commonly low physiological nutrient concentrations. Promoted epithelial-fibroblast interactions result in modulated protein signal transduction and expression of genes regulating gut barrier integrity. Overall, the e-transmembrane gut barrier more closely mimicked physiological effects for humans as demonstrated using the dietary compound butyrate.
Authors
- Magdalena E Strauß (ORCID: https://orcid.org/0000-0002-6089-8049)
- Kumar Thurimella (ORCID: https://orcid.org/0000-0002-0819-4378)
- Jory Lietard (ORCID: https://orcid.org/0000-0003-4523-6001)
- Erika Schaudy (ORCID: https://orcid.org/0000-0002-2803-6684)
- Jonathan E. Clark (ORCID: https://orcid.org/0000-0002-6790-013X)
- Chrysanthi‐Maria Moysidou (ORCID: https://orcid.org/0000-0001-9809-2764)
- Shani Elias‐Kirma (ORCID: https://orcid.org/0000-0002-4859-7120)
- Verena Stoeger (ORCID: https://orcid.org/0000-0003-0867-3042)
- Izabella Niewczas (ORCID: https://orcid.org/0000-0003-1672-5033)
- Stephen Voong
- Christopher Gerner
- Etkin Parlar
Institutions
- University of Vienna (AT)
- Babraham Institute (GB)
- European Bioinformatics Institute (GB)
- University of Cambridge (GB)
- University of Colorado System (US)
- Bridge University (SS)
- University of Colorado Denver (US)
Publication Details
- Journal
- Advanced Biology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/adbi.202500409
- Citations
- 1
- Primary Topic
- Effects and risks of endocrine disrupting chemicals
- Type
- article
- Field-Weighted Citation Impact
- 31.09
Funders
- Wellcome Trust
- European Commission
- Cambridge Trust
- Gates Cambridge Trust